JP7874887B2 - Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 - Google Patents

Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態

Info

Publication number
JP7874887B2
JP7874887B2 JP2023549823A JP2023549823A JP7874887B2 JP 7874887 B2 JP7874887 B2 JP 7874887B2 JP 2023549823 A JP2023549823 A JP 2023549823A JP 2023549823 A JP2023549823 A JP 2023549823A JP 7874887 B2 JP7874887 B2 JP 7874887B2
Authority
JP
Japan
Prior art keywords
citrate
compound
weight
hemi
hemy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023549823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506942A5 (cg-RX-API-DMAC10.html
JP2024506942A (ja
Inventor
ドリス ネヴィル
アフマド ハシャシュ
カール ハンセン
ヨハン チャン
Original Assignee
プラクシス プレシジョン メディシンズ, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プラクシス プレシジョン メディシンズ, インコーポレイテッド filed Critical プラクシス プレシジョン メディシンズ, インコーポレイテッド
Publication of JP2024506942A publication Critical patent/JP2024506942A/ja
Publication of JP2024506942A5 publication Critical patent/JP2024506942A5/ja
Priority to JP2026025898A priority Critical patent/JP2026097871A/ja
Application granted granted Critical
Publication of JP7874887B2 publication Critical patent/JP7874887B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
JP2023549823A 2021-02-18 2022-02-16 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態 Active JP7874887B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026025898A JP2026097871A (ja) 2021-02-18 2026-02-20 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163150782P 2021-02-18 2021-02-18
US63/150,782 2021-02-18
PCT/US2022/016612 WO2022178000A1 (en) 2021-02-18 2022-02-16 Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026025898A Division JP2026097871A (ja) 2021-02-18 2026-02-20 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態

Publications (3)

Publication Number Publication Date
JP2024506942A JP2024506942A (ja) 2024-02-15
JP2024506942A5 JP2024506942A5 (cg-RX-API-DMAC10.html) 2025-02-25
JP7874887B2 true JP7874887B2 (ja) 2026-06-17

Family

ID=82931143

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023549823A Active JP7874887B2 (ja) 2021-02-18 2022-02-16 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態
JP2026025898A Pending JP2026097871A (ja) 2021-02-18 2026-02-20 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026025898A Pending JP2026097871A (ja) 2021-02-18 2026-02-20 Gaba-aポジティブアロステリック調節物質のヘミ-クエン酸塩およびその結晶形態

Country Status (5)

Country Link
US (2) US20240190910A1 (cg-RX-API-DMAC10.html)
EP (1) EP4294819A4 (cg-RX-API-DMAC10.html)
JP (2) JP7874887B2 (cg-RX-API-DMAC10.html)
TW (1) TW202245790A (cg-RX-API-DMAC10.html)
WO (1) WO2022178000A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10562930B1 (en) 2018-08-31 2020-02-18 Praxis Precision Medicines, Inc. Salts and crystal forms of GABAA positive allosteric modulator
EP4514357A4 (en) * 2022-04-26 2026-04-29 Praxis Prec Medicines Inc METHODS OF TREATING NEUROLOGICAL DISORDERS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504297A (ja) 2018-08-31 2021-02-15 プラクシス プレシジョン メディスンズ,インコーポレイテッドPraxis Precision Medicines,Inc. Gabaaの正のアロステリックモジュレーターの塩及び結晶形態

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
US20060074059A1 (en) * 2004-08-26 2006-04-06 Goliber Philip A Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one
DK2168585T3 (da) * 2005-06-09 2012-02-27 Euro Celtique Sa Farmaceutiske sammensætninger af en neuroaktiv steroid og anvendelser deraf

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504297A (ja) 2018-08-31 2021-02-15 プラクシス プレシジョン メディスンズ,インコーポレイテッドPraxis Precision Medicines,Inc. Gabaaの正のアロステリックモジュレーターの塩及び結晶形態

Also Published As

Publication number Publication date
US20220289789A1 (en) 2022-09-15
US11697669B2 (en) 2023-07-11
TW202245790A (zh) 2022-12-01
US20240190910A1 (en) 2024-06-13
EP4294819A4 (en) 2024-12-18
JP2026097871A (ja) 2026-06-16
WO2022178000A1 (en) 2022-08-25
EP4294819A1 (en) 2023-12-27
JP2024506942A (ja) 2024-02-15

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250527

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250818

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260519

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260529

R150 Certificate of patent or registration of utility model

Ref document number: 7874887

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150